On 8/9/24, Iovance Biotherapeutics Inc (NASDAQ: IOVA) stock enjoyed a major increase of 24.9%, closing at $9.92. Moreover, this advance was accompanied by exceptionally high trading volume at 311% of normal. Relative to the market the stock has been strong over the last nine months and has risen 21.6% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, IOVA is expected to continue to be Value Creation neutral.
Iovance Biotherapeutics has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Iovance Biotherapeutics has a very low Appreciation Score of 9 but a slightly positive Power Rating of 68, with the Negative Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment